How would you follow up neovascular ARMD after loading dose?

A 72 years old lady presented to me with a history of wet ARMD and has been treated with three injections of Ranibizumab and one injection of Aflibercept, which has been administered six weeks ago with no systemic history; her BCVA is 20/100. Her other eyes show intermediate non-neovascular ARMD

Fundus image

Her Fundus image shows RPE degeneration along with sub RPE scar and Small areas of RPE detachment and drusen.

Fundus image showing fibrovascular ARMD

Fundus Fluorescein angiography

Her FFA shows hyperfluorescence stippled changes parafoveal area which persists and increases in intensity in late stages of angiogram which presents fibrovascular pigment epithelial detachments with RPE degeneration at the central macula.

Early phase of FFA showing stippled hyperfluorescence

Mid phase of FFA showing stippled hyperfluorescence

Late phase of FFA showing stippled hyperfluorescence

Optical coherence tomography

Her Radial OCT scans show irregular RPE detachments with fibrovascular continents and disturbed ellipsoid zone in the inferior nasal to the superior temporal line.

OCT radial scan shows fibrovascular PED

In contrast, the superior nasal to inferior temporal line shows fibrovascular RPE detachment with RPE degeneration and disturbed ellipsoid zone. In the OCT scans, there is no subretinal nor intraretinal fluids.

OCT line scan shows fibrovascular PED

The diagnosis is ARMD with fibrovascular PED

Management

Once the patient already received four anti-VEGF injections, and there are no subretinal nor intraretinal cysts. This means that the lesion is subsiding but still not deactivated completely. So it is wise to switch the patient from monthly injections to treat and extend protocol, which features injecting six weeks after the last monthly injection, then repeat OCT within two months if there is an improvement or no changes, then reinject. Repeat OCT within three months if there is an improvement or no changes. OCT and injection can be repeated every three months. Follow-up should never exceed 12 weeks, in case the of worsening is noted on OCT during treat and extend protocol then switch back to monthly injection.

I have chosen this patient to treat her with intravitreal Aflibercept using a treat and extend protocol because Aflibercept is more effective in treating PED than other commercially available anti-VEGF.

Please check clinical guidelines for Age-related macular degeneration

#INTERPRET_OCT #FFA #Treat_and_Extend #ARMD #PED #Wet #Aflibercept #injection #Intravitreal

Comments

Cellophane maculopathy

Caused by an epiretinal membrane, clinically, it appears as a sheen abnormal foveal reflex which features epiretinal membrane, due to inflammatory mediators and proliferation of glial cells secondary to a partial separation of posterior cortical vitreous. Fundus image shows cellophane maculopathy OCT features a hyperreflective band covering the inner retinal layers, causing minimal disturbance of inner retinal tissues. OCT cross-section shows epiretinal membrane Cellophane maculopathy itself in individuals with good visual acuity may not need any interventions, but it is warranted to do a detailed peripheral retinal exam to rule out retinal tear or hole However, an epiretinal membrane may proliferate further and cause additional tangential traction. Thus, it may induce macular pucker or lamellar/pseudo hole and increase disturbance of inner retinal tissues, macular thickness, and reduction of vision. These patients may require pars plana vitrectomy to remove the epiretinal membran...

Adult-onset vitelliform macular dystrophy

One of the most common pattern dystrophies similar to best occurs in adulthood, as it appears as oval or yellowish macular material, originated from the debris of photoreceptors, or the RPE phagocytosis failure. Fundus image showing Adult-onset vitelliform macular dystrophy On OCT, it appears as subretinal vitelliform material accumulation but above the RPE with intact ellipsoid zone and thus explains good visual acuity without an increase in retinal thickness. OCT cross-section showing Adult-onset vitelliform macular dystrophy Fluorescein angiography typically shows hypo-fluorescence at the area of vitelliform accumulation surrounded with hyper-fluorescence increases intensity in late phases; however, it may show liner, patchy, or ring-like, which is inconsistent with visual acuity. Adult-onset vitelliform macular dystrophy itself does not warrant any treatment; however, a regular follow up to monitor any progression to choroidal neovascularization. How would you approa...

Chronic Central Serous Chorioretinopathy fundus image, OCT and FFA in a nutshell

CSCR is a spectrum of pachychoroid FFA, OCT, and Fundus image can aid in the diagnosis and the follow-up. Fundus image Chronic CSR appears as granular RPE changes along with subretinal fluid and PED. Fundus image showing granular RPE changes due to chronic CSCR Optical coherence tomography OCT shows central subretinal fluid with PED and visible with granular changes of the RPE, along with elongation of photoreceptor cells and increased the thickness of choroid and dilated of Haller's. OCT cross-section showing chronic CSCR featuring subretinal fluids and RPE granular changes Fluorescein Fundus Angiography FFA shows a granular hyper fluorescence in the early through late-phase along with subretinal dye pooling and under the RPE in late phases. Early FFA phase showing granular hyperfluorescence Mid FFA phase showing the increased intensity of granular hyperfluorescence Late phase showing Mid FFA phase showing the increased intensity of granular hyperfluorescence wi...

Retinal Assistant Module Blog

Search This Blog